Early control or gradual relief? Gender-specific real-world insights into omalizumab response in chronic spontaneous urticaria patients

Background: Chronic spontaneous urticaria (CSU) disproportionately affects women, yet gender-specific analyses in treatment response remain scarce. Real-world data on the impact of gender on omalizumab efficacy are limited. Objective: To investigate gender-specific differences in clinical characteri...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Sarah Preis, MD, Milena Lisiecki, Tilo Biedermann, MD, Sophia Horster, MD, Alexander Zink, MD, PhD
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2026-01-01
Reeks:	World Allergy Organization Journal
Onderwerpen:	Vurticaria omalizumab gender
Online toegang:	http://www.sciencedirect.com/science/article/pii/S1939455125001401
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!